F. Innocenti

967 total citations
25 papers, 676 citations indexed

About

F. Innocenti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, F. Innocenti has authored 25 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in F. Innocenti's work include Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). F. Innocenti is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). F. Innocenti collaborates with scholars based in Italy, United States and Czechia. F. Innocenti's co-authors include Giulia Picozzi, Mario Mascalchi, Michela Grazzini, Laura Carrozzi, Fabio Falaschi, Francesca Maria Carozzi, Andrea Lopes Pegna, Euǵenio Paci, Camilla Comin and Cheti Spinelli and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

F. Innocenti

24 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Innocenti Italy 10 367 211 198 174 61 25 676
Emily Robinson United States 9 166 0.5× 159 0.8× 43 0.2× 234 1.3× 37 0.6× 15 588
Nurcan Başar Türkiye 12 77 0.2× 221 1.0× 105 0.5× 349 2.0× 144 2.4× 30 655
Mona Wahba United Kingdom 10 313 0.9× 210 1.0× 246 1.2× 38 0.2× 120 2.0× 34 598
Tarık Esen Türkiye 18 751 2.0× 67 0.3× 185 0.9× 29 0.2× 156 2.6× 85 1.0k
Andreea Varga Romania 13 118 0.3× 168 0.8× 32 0.2× 86 0.5× 53 0.9× 60 470
K Lindvig Denmark 8 107 0.3× 184 0.9× 237 1.2× 267 1.5× 112 1.8× 11 757
Deborah L. Morris United States 6 172 0.5× 47 0.2× 197 1.0× 272 1.6× 123 2.0× 13 562
Pilar Auñón Spain 12 153 0.4× 179 0.8× 124 0.6× 206 1.2× 48 0.8× 40 546
Sebastian Szmit Poland 16 296 0.8× 238 1.1× 155 0.8× 585 3.4× 74 1.2× 88 901
L. Rytter Denmark 10 71 0.2× 94 0.4× 73 0.4× 128 0.7× 61 1.0× 12 455

Countries citing papers authored by F. Innocenti

Since Specialization
Citations

This map shows the geographic impact of F. Innocenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Innocenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Innocenti more than expected).

Fields of papers citing papers by F. Innocenti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Innocenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Innocenti. The network helps show where F. Innocenti may publish in the future.

Co-authorship network of co-authors of F. Innocenti

This figure shows the co-authorship network connecting the top 25 collaborators of F. Innocenti. A scholar is included among the top collaborators of F. Innocenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Innocenti. F. Innocenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cimadomo, Danilo, F. Innocenti, Silvia Colamaria, et al.. (2024). O-301 Progesterone Primed Ovarian Stimulation (PPOS) for DuoStim combined with PGT-A in poor prognosis patients: a valuable strategy. Human Reproduction. 39(Supplement_1). 1 indexed citations
2.
Innocenti, F., Lisa Dovere, Vincenzo Arena, et al.. (2024). Role of thyroid stimulating hormone in the maintenance and functioning of the human corpus luteum. Journal of Endocrinological Investigation. 47(7). 1719–1732. 1 indexed citations
3.
Pegna, Andrea Lopes, Giulia Picozzi, Fabio Falaschi, et al.. (2013). Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial. Journal of Thoracic Oncology. 8(7). 866–875. 100 indexed citations
4.
Innocenti, F., Theodore Karrison, Jacqueline Ramı́rez, et al.. (2010). Effect of coadministration of statins on neutropenia in a phase I genotype-directed dose-escalation study of irinotecan.. Journal of Clinical Oncology. 28(15_suppl). 3020–3020. 1 indexed citations
5.
Carozzi, Francesca Maria, Simonetta Bisanzi, Patrizia Falini, et al.. (2009). Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis. Lung Cancer. 68(2). 216–221. 10 indexed citations
6.
Picozzi, Giulia, et al.. (2009). MRI features of pleural endometriosis after catamenial haemothorax. BMJ Case Reports. 2009. bcr2006071415–bcr2006071415. 3 indexed citations
7.
Picozzi, Giulia, et al.. (2009). MRI features of pleural endometriosis after catamenial haemothorax. BMJ Case Reports. 2009. bcr0920080903–bcr0920080903. 9 indexed citations
8.
Tibaldi, Carmelo, Enrico Vasile, Andrea Antonuzzo, et al.. (2008). First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study. British Journal of Cancer. 98(3). 558–563. 8 indexed citations
9.
Pegna, Andrea Lopes, Giulia Picozzi, Mario Mascalchi, et al.. (2008). Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer. 64(1). 34–40. 226 indexed citations
10.
Picozzi, Giulia, et al.. (2007). MRI features of pleural endometriosis after catamenial haemothorax. Thorax. 62(8). 744–744. 19 indexed citations
11.
Tibaldi, Carmelo, Tiziana Prochilo, M.C. Pennucci, et al.. (2006). Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I–II study. British Journal of Cancer. 94(9). 1263–1266. 3 indexed citations
12.
Innocenti, F., Samir D. Undevia, Gary L. Rosner, et al.. (2005). Irinotecan (CPT-11) pharmacokinetics (PK) and neutropenia: interaction among UGT1A1 and transporter genes. Journal of Clinical Oncology. 23(16_suppl). 2006–2006. 9 indexed citations
13.
Tibaldi, Carmelo, Serafino Ricci, Ilaria Bernardini, et al.. (2004). Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the “polmone toscano group” (POLTO). Lung Cancer. 48(1). 121–127. 7 indexed citations
14.
Bengala, Carmelo, Romano Danesi, Valentina Guarneri, et al.. (2003). High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine–epirubicin–paclitaxel in metastatic breast cancer: a dose finding study. Bone Marrow Transplantation. 31(4). 275–280. 7 indexed citations
15.
Bocci, Guido, Romano Danesi, Giacomo Allegrini, et al.. (2002). Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case report. European Journal of Clinical Pharmacology. 58(9). 593–595. 11 indexed citations
16.
Bengala, Carmelo, F. Innocenti, Sara Donati, et al.. (2001). High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC). Annals of Oncology. 12(1). 69–74. 10 indexed citations
17.
Conté, Pierfranco, Editta Baldini, Alessandra Gennari, et al.. (1997). Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer.. Journal of Clinical Oncology. 15(7). 2510–2517. 80 indexed citations
18.
Piperno, Gaia, et al.. (1996). [Renal artery occlusion diagnosed with spiral computerized tomography (CT-angiography). Report of a case and comparison with other imaging techniques].. PubMed. 92(4). 484–6.
19.
Seghieri, Giuseppe, et al.. (1989). Serum digoxin and beta-methyldigoxin in elderly patients on hospital admission: correlation with home compliance and clinical variables. European Journal of Clinical Pharmacology. 37(4). 401–404. 4 indexed citations
20.
Giaconi, S, et al.. (1989). Microalbuminuria and Casual and Ambulatory Blood Pressure Monitoring in Normotensives and in Patients With Borderline and Mild Essential Hypertension. American Journal of Hypertension. 2(4). 259–261. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily Robinson Breakdown of academic impact, for papers by Nurcan Başar Breakdown of academic impact, for papers by Mona Wahba Breakdown of academic impact, for papers by Tarık Esen Breakdown of academic impact, for papers by Andreea Varga Breakdown of academic impact, for papers by K Lindvig Breakdown of academic impact, for papers by Deborah L. Morris Breakdown of academic impact, for papers by Pilar Auñón Breakdown of academic impact, for papers by Sebastian Szmit Breakdown of academic impact, for papers by L. Rytter
Rankless by CCL
2026